Newsroom

10 November 2021

ScaleReady Launches Second Generation of Wilson Wolf G-Rex Product

The second generation G-Rex500M-CS improves on the materials and ergonomics of the original G-Rex while retaining the same cell expansion...

3 November 2021

Bio-Techne Releases First GMP-grade Cytokines from New GMP Facility

ScaleReady sources Bio-Techne cytokines because of their commitment to supplying the entire cell and gene therapy industry with GMP-grade, animal...

7 October 2021

CancerNetworks Interviews ScaleReady

Josh Ludgwig, Global Director of Commercial Operations at ScaleReady discusses what makes the company uniquely positioned to support manufacturing across...

1 October 2021

ScaleReady Joins the Alliance for Regenerative Medicine

As a member of The Alliance for Regenerative Medicine (ARM), ScaleReady committed to progressing regenerative medicine and advanced therapy manufacturing...

2 June 2021

ScaleReady hosts ISCT Symposium on Intelligent Scale-up

ScaleReady recruited a prestigious panel of cell therapy manufacturing experts to discuss their experiences and strategies for commercial scale up...

25 May 2021

RegMedNet interviews Josh Ludwig, Global Commercial Director

In this interview, Josh Ludwig, Global Director of Commercial Operations at ScaleReady, describes how a scalable, cost-effective and practical manufacturing...

6 January 2021

ScaleReady Launches

ScaleReady launches with the mission to make cell and gene therapy manufacturing practical and viable. Through a partnership between Bio-Techne,...

21 January 2020

Joint Venture formed by Bio-Techne, Fresenius Kabi, and Wilson Wolf

The joint venture focuses on providing scalable manufacturing technologies needed to develop and commercialize new cell and gene therapies. Each...